SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-026242
Filing Date
2022-10-11
Accepted
2022-10-11 16:20:18
Documents
2
Period of Report
2022-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166551960375948.html 3  
1 FORM 3 wf-form3_166551960375948.xml 3 1704
2 FORM 3 (CONTINUED) ex-24.htm EX-24 3703
  Complete submission text file 0001628280-22-026242.txt   6821
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39614 | Film No.: 221304303

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)